Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma — Stella

Recruiting

Back to Renal Cell Carcinoma (RCC) trials

Trial locations(1 site)

China

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

Key details

Sponsor

The Affiliated Hospital of Qingdao University

Collaborators

Qianfoshan Hospital, Weifang People's Hospital

Enrollment target

~40 participants

Started

April 2025

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov